Vistagen Therapeutics, Inc. · NASDAQ:VTGN
The Vanguard Group reported a 5.50% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 31, 2025
The Vanguard Group reported a 5.50% stake in Vistagen Therapeutics, Inc., 1,687,735 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 1,687,735
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.50% | 1,687,735 |
Source
Related
- Vistagen Therapeutics, Inc.
- The Vanguard Group
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026